Company intelligence / Profile preview

Metrodora Institute

West Valley City, Utah, United States

Ownership: Private
Development stage: Other

Overview

Metrodora Institute delivered multidisciplinary clinical care and advanced diagnostics for neuroimmune and complex chronic conditions, integrating AI-powered biobanking, genomics, and real-world data. The institute conducted collaborative clinical research and formed platform partnerships for biomarker discovery and drug repurposing, but appears to have ceased operations as of 2024[4].

Therapeutic areas: CardiovascularImmunologyRheumatologyGastroenterologyInfectious DiseasesNeurologyWomen's HealthMetabolic Disorders
Industry: Academic Hospital/University/Research

Partnerships

PrecisionLife (precision medicine/genomic diagnostics)[5]PathAI (AI diagnostics/pathology)[3]Fabric Genomics (AI genomic analysis)[3]NeuraLight (AI neurological diagnostics)[3]Biofourmis (remote monitoring/analytics)[3]

Beyond the preview

Go deeper on Metrodora Institute.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Metrodora Institute.

Explore the full profile